SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017336
Filing Date
2019-11-14
Accepted
2019-11-14 13:52:06
Documents
45
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 346996
2 ex31-1.htm EX-31.1 11093
3 ex31-2.htm EX-31.2 11111
4 ex32-1.htm EX-32.1 5722
5 ex32-2.htm EX-32.2 6158
  Complete submission text file 0001493152-19-017336.txt   2596121

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20190930.xml EX-101.INS 388416
7 XBRL SCHEMA FILE capd-20190930.xsd EX-101.SCH 28649
8 XBRL CALCULATION FILE capd-20190930_cal.xml EX-101.CAL 34419
9 XBRL DEFINITION FILE capd-20190930_def.xml EX-101.DEF 97646
10 XBRL LABEL FILE capd-20190930_lab.xml EX-101.LAB 197119
11 XBRL PRESENTATION FILE capd-20190930_pre.xml EX-101.PRE 155411
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26027 | Film No.: 191218716
SIC: 2834 Pharmaceutical Preparations